UPDATE: Cowen Downgrades Spero Therapeutics (SPRO) to Market Perform
Tweet Send to a Friend
(Updated - May 4, 2022 5:33 AM EDT)
Cowen analyst Ritu Baral downgraded Spero Therapeutics (NASDAQ: SPRO) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cowen analyst Ritu Baral downgraded Spero Therapeutics (NASDAQ: SPRO) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE